CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study 期刊论文
2019, 卷号: 257, 期号: 3, 页码: 529-541
作者:  Li, Xiaoxin;  Dai, Hong;  Li, Xiaorong;  Han, Mei;  Li, Jun
收藏  |  浏览/下载:175/0  |  提交时间:2020/01/03
An In Vivo Microdialysis Study of FLZ Penetration through the Blood-Brain Barrier in Normal and 6-Hydroxydopamine Induced Parkinson's Disease Model Rats 期刊论文
2014, 卷号: 2014, 页码: 850493
作者:  Hou, Jinfeng;  Liu, Qian;  Li, Yingfei;  Sun, Hua;  Zhang, Jinlan
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/13
P-Glycoprotein Mediated Efflux Limits the Transport of the Novel Anti-Parkinson's Disease Candidate Drug FLZ across the Physiological and PD Pathological In Vitro BBB Models 期刊论文
2014, 卷号: 9, 期号: 7, 页码: e102442
作者:  Liu, Qian;  Hou, Jinfeng;  Chen, Xiaoguang;  Liu, Gengtao;  Zhang, Dan
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13
HPLC-MS and HPLC MS/MS analysis of seven active constituents of Xiao-Xu-Ming decoction and application to a pharmacokinetic study after oral administration to rat 期刊论文
2012, 卷号: 2, 期号: 2, 页码: 188-197
作者:  Wang, Yilin;  Ding, Chunguang;  Wu, Caisheng;  Du, Kehe;  Zhang, Jinlan
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/13
Quantitative determination and pharmacokinetic study of the novel anti-Parkinson's disease candidate drug FLZ in rat brain by high performance liquid chromatography-tandem mass spectrometry 期刊论文
2012, 卷号: 66, 页码: 232-239
作者:  Hou, Jinfeng;  Qu, Feng;  Wu, Caisheng;  Ren, Qiang;  Zhang, Jinlan
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace